Cargando…
Beyond SMARCB1 Loss: Recent Insights into the Pathobiology of Epithelioid Sarcoma
Epithelioid sarcoma (ES) is a very rare and aggressive mesenchymal tumor of unclear origin and uncertain lineage characterized by a prevalent epithelioid morphology. The only recurrent genetic alteration reported in ES as yet is the functional inactivation of SMARCB1 (SWI/SNF-related matrix-associat...
Autores principales: | Del Savio, Elisa, Maestro, Roberta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454995/ https://www.ncbi.nlm.nih.gov/pubmed/36078034 http://dx.doi.org/10.3390/cells11172626 |
Ejemplares similares
-
Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions
por: Sullivan, Lisa M., et al.
Publicado: (2012) -
An Adrenal SMARCB1/INI1 Deficient Proximal Epithelioid Sarcoma in a Middle-Aged Female: A Case Report
por: Brodie, Zachary, et al.
Publicado: (2022) -
Immunotherapy for SMARCB1-Deficient Sarcomas: Current Evidence and Future Developments
por: Ngo, Carine, et al.
Publicado: (2022) -
Latest developments in the pathobiology of Ewing sarcoma
por: Karlina, Irina, et al.
Publicado: (2022) -
SMARCB1-Deficient Cancers: Novel Molecular Insights and Therapeutic Vulnerabilities
por: Cooper, Garrett W., et al.
Publicado: (2022)